Diabetic Lancing Device Market Research Report-  Global  Forecast To 2027

Diabetic lancing device market research report– By type (push button safety lancets, pressure activated safety lancets, side button safety lancets), by gauge (17/18g, 21g, 23g, 25g, 28g,  30g), by penetration depth, by end-user – Global forecast till 2027

ID: MRFR/MED/4060-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario:


Diabetes is a global epidemic affecting an estimated 382 million people worldwide. The WHO projects that diabetes will be the 7th leading cause of death by 2030. An estimated 4 million people die annually from the complications associated with diabetes. Therefore, if the current trend associated with the prevalence of diabetes continues over the coming years, the number of diabetic patients across the globe would be tremendous after a decade. Increasing prevalence of diabetes will result in the rising demand for devices and products to monitor and control diabetes, eventually leading to increased consumption of lancets. Thus, the demand for lancets is expected to be enormous in the coming future.


Lancets are one of the widely used alternative device to obtain the blood samples. These devices are receiving global recognition and acceptance due to its several convenient characteristics which gives them an edge over the traditional methods for vein puncture. Some of the important features of the safety lancets are painless vein puncture, easy handling, and safety while using. The major applications of the lancets are HIV screening test, capillary blood micro sampling and cholesterol test, blood group test, coagulation tests, haemoglobin, allergy tests, and many other blood based tests. According to the International Diabetes Federation (IDF), approximately 29.2 million people in the US are estimated suffer from diabetes in 2015. Japan had approximately 7.2 million. in 2015.


Rising prevalence of diabetic population, increasing awareness for blood glucose monitoring device and increased awareness of safety measures in order to avoid the infectious diseases are some of the significant factors of the increased awareness and use of lancets. However, the price erosion is a major issue that is negatively impacting the diabetes management devices. Moreover, significant changes in reimbursement policies in the US for blood glucose monitors, particularly the ongoing impact to the private insurance sector are some of the factors restraining the growth of diabetic lancing device market.


The global diabetic lancing device market is expected to grow at a CAGR of approximately 11.0% during the forecast period 2017-2023.


Research Methodology:


 Research Methodology


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Diabetic Lancing Device Suppliers

  • Diabetic Lancing Device Manufacturers

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Segmentation:


The global diabetic lancing devices market is segmented on the basis of type, gauge, penetration depth, and end user.


On the basis of type, the market for diabetic lancing devices it is segmented into safety lancets and standard lancets. The safety lancets are further categorized into push-button safety lancets, pressure activated safety lancets, and side button safety lancets. The pen needles is further categorized into standard pen needles and safety pen needles.


On the basis of gauge, the market for diabetic lancing devices it is segmented into 17/18g, 21g, 23g, 25g, 28g,  30g, and others.


On the basis of penetration depth, the market for diabetic lancing devices it is segmented into 0.8 mm to 1.0 mm, 1.1 mm to 1.5 mm, 1.6 mm to 2.0 mm, 2.1 mm to 2.5 mm, 2.5 mm to 3.0 mm, and others.


On the basis of the end users, it is segmented into hospitals & clinics, diagnostic centers & medical institutions, home care & home diagnostics, research & academic laboratories, and others.


Regional Analysis:


The global diabetic lancing device market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.


Europe is projected to hold the largest share of the global diabetic lancing device market attributed to change in lifestyle, increase in R&D activities for the development of new drugs.  According to the International Diabetes Federation (IDF), in 2015 approximately 59.8 million people had diabetes in Europe. HTL Strefa and Sarstedt are two European companies which have marked their presence on the global level as a major manufacturer of lancets and safety lancets in the world.


The Americas holds a key share in diabetic lancing device treatment market. Moreover, North America dominated the overall market in terms of revenue in 2016. In the U.S., ongoing uncertainty as to the future of the Affordable Care Act and the Trump Administration’s repeal and replace initiative may further impact the market.


Asia Pacific is estimated to be the fastest region to  grow at a high CAGR during the forecast period, led by an increase in government spending on healthcare services in India and China. A large number of lancet manufacturers are from developing Asian countries such as China, India, Japan and Republic of Korea mainly because of the low labour cost and low R&D cost. China being one of the highly populated and technologically advanced developing countries, has a major number of lancets manufacturers. Some of the renowned Chinese Safety Lancet manufacturers are Guangzhou Improve Medical Instruments Co, Huang and KDL China.


The Middle East & Africa is projected to expand during the forecast period, owing to the rise in investments by market players and increase in prevalence of diabetic lancing devices.


Key Players:


Some of the key players in the global diabetic lancing devices market are B. Braun Melsungen AG, Terumo Corporation, Becton Dickinson, Sanofi, F. Hoffmann-La Roche AG, Bayer AG, Novo Nordisk A S, Eli Lilly and Company, Owen Mumford Ltd, Medtronic, Ypsomed Holding AG, Sarstedt AG & Co, Greiner Bio One, Abbott Laboratories, HTL-STREFA S.A, Improve Medical, UltiMed, Inc., Allison Medical, Inc., Artsana S.p.a., VOGT MEDICAL, Perrigo Diabetes Care, MedExel Co., Ltd, ARKRAY Inc., Simple Diagnostics, Stat Medical, Terumo, Trividia Health, and others.



Frequently Asked Questions (FAQ) :


diabetic lancing device market is projected to grow at approximately 11.0% CAGR during the assessment period (2017-2023).

Features of these devices such as painless vein puncture, easy handling, and safety, rising prevalence of diabetic population, and increasing awareness for blood glucose monitoring device, are major tailwinds pushing the growth of the global diabetic lancing device market.

High price and significant changes in reimbursement policies blood glucose monitors, are major growth impeder for the global diabetic lancing device market.

Europe holds the largest share in the global diabetic lancing device market, followed by North America and the Asia Pacific, respectively.

B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Sanofi, F. Hoffmann-La Roche AG, Novo Nordisk A S, Bayer AG, Eli Lilly and Company, Medtronic, Owen Mumford Ltd, Ypsomed Holding AG, Greiner Bio One, Sarstedt AG & Co, Abbott Laboratories, Improve Medical, HTL-STREFA S.A, UltiMed, Inc., Artsana S.p.a., Allison Medical, Inc., VOGT MEDICAL, MedExel Co., Ltd, Perrigo Diabetes Care, ARKRAY Inc., Stat Medical, Simple Diagnostics, Terumo, and Trividia Health, are some of the top players operating in the global diabetic lancing device market.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Treatment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Diabetic Lancing Device Market, By Type

6.1 Introduction

6.2 Standard Lancet

6.2.1 Market Estimates & Forecast, 2020 – 2023

6.5 Safety Lancet

6.5.1 Market Estimates & Forecast, 2020 – 2023

6.5.2 Push Button Safety Lancets

6.5.2.1 Market Estimates & Forecast, 2020 – 2023

6.5.3 Pressure Activated Safety Lancets

6.5.3.1 Market Estimates & Forecast, 2020 – 2023

6.5.4 Side Button Safety Lancets

6.5.4.1 Market Estimates & Forecast, 2020 – 2023

6.6 Others

Chapter 7. Global Diabetic Lancing Device Market, By Gauge

7.1 Introduction

7.2 17/18G

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 21G

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 23G

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 25G

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 28G

7.6.1 Market Estimates & Forecast, 2020 – 2027

7.7 30G

7.7.1 Market Estimates & Forecast, 2020 – 2027

Chapter 8. Global Diabetic Lancing Device Market, By Penetration Depth

8.1 Introduction

8.2 0.8 Mm To 1.0 Mm

8.2.1 Market Estimates & Forecast, 2018 – 2023

8.3 1.1 Mm To 1.5 Mm

8.3.1 Market Estimates & Forecast, 2018 – 2023

8.4 1.6 Mm To 2.0 Mm

8.4.1 Market Estimates & Forecast, 2018 – 2023

8.5 2.1 Mm To 2.5 Mm

8.5.1 Market Estimates & Forecast, 2018 – 2023

8.6 2.5 Mm To 3.0 Mm

8.6.1 Market Estimates & Forecast, 2018 – 2023

8.7 Others

Chapter 9. Global Diabetic Lancing Device Market, By End User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2020 – 2027

9.3 Diagnostic Centers And Pathology Laboratories

9.3.1 Market Estimates & Forecast, 2020 – 2027

9.4 Home Diagnostics

9.4.1 Market Estimates & Forecast, 2020 – 2027

9.5 Others

Chapter. 10 Global Diabetic Lancing Device Market, By Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Rest Of The Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 HTL-STREFA S.A.

12.1.1 Company Overview

12.1.2 Business Segment Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Becton, Dickinson And Company

12.2.1 Company Overview

12.2.2 Business Segment Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Greiner Bio One International GmbH

12.3.1 Company Overview

12.3.2 Business Segment Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Improve Medical Technology Co. Ltd

12.4.1 Company Overview

12.4.2 Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Terumo Medical Corporation

12.5.1 Company Overview

12.5.2 Business Segment Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 ASAHI POLYSLIDER Inc.

12.6.1 Company Overview

12.6.2 Business Segment Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 ARKRAY

12.7.1 Overview

12.7.2 Business Segment Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Sarstedt AG & Co.

12.8.1 Company Overview

12.8.2 Business Segment Overview

12.8.3 Financial Overview

12.8.4 Key Development

12.8.5 SWOT Analysis

12.9 Abbott Laboratories

12.9.1 Overview

12.9.2 Product/Business Segment Overview

12.9.3 Financial Updates

12.9.4 Key Developments

12.10 Smiths Medical

12.10.1 Company Overview

12.10.2 Product/Business Segment Overview

12.10.3 Financial Updates

12.10.4 Key Development

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Pharmaceutical Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Diabetic Lancing Device Industry Synopsis, 2020 – 2027

Table 2 Diabetic Lancing Device Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Diabetic Lancing Device Market By Region, 2020 – 2027, (USD Million)

Table 4 Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 5 Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 6 Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 7 Diabetic Lancing Device Market By End Users, 2020 – 2027, (USD Million)

Table 8 North America Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 9 North America Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 12 North America Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 11 North America Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 12 US Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 13 US Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 14 US Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 15 US Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 16 Canada Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 17 Canada Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 18 Canada Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 19 Canada Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 20 South America Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 21 South America Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 22 South America Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 23 South America Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 24 Europe Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 25 Europe Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 26 Europe Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 27 Europe Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 28 Western Europe Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 29 Western Europe Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 30 Western Europe Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 31 Western Europe Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

Table 40 The Middle East & Africa Diabetic Lancing Device Market By Type, 2020 – 2027, (USD Million)

Table 41 The Middle East & Africa Diabetic Lancing Device Market By Gauge, 2020 – 2027, (USD Million)

Table 42 The Middle East & Africa Diabetic Lancing Device Market By Penetration Depth, 2020 – 2027, (USD Million)

Table 43 The Middle East & Africa Diabetic Lancing Device Market By End User, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Diabetic Lancing Device Market

Figure 3 Segmentation Market Dynamics For Diabetic Lancing Device Market

Figure 4 Global Diabetic Lancing Device Market Share, By Type 2020

Figure 5 Global Diabetic Lancing Device Market Share, By Gauge 2020

Figure 6 Global Diabetic Lancing Device Market Share, By Penetration Depth, 2020

Figure 7 Global Diabetic Lancing Device Market Share, By End Users, 2020

Figure 9 Global Diabetic Lancing Device Market Share, By Region, 2020

Figure 12 North America Diabetic Lancing Device Market Share, By Country, 2020

Figure 11 Europe Diabetic Lancing Device Market Share, By Country, 2020

Figure 12 Asia Pacific Diabetic Lancing Device Market Share, By Country, 2020

Figure 13 The Middle East & Africa Diabetic Lancing Device Market Share, By Country, 2020

Figure 14 Global Diabetic Lancing Device Market: Company Share Analysis, 2020 (%)

Figure 15 HTL-STREFA S.A.: Key Financials

Figure 16 HTL-STREFA S.A.: Segmental Revenue

Figure 17 HTL-STREFA S.A.: Geographical Revenue

Figure 18 Becton, Dickinson And Company: Key Financials

Figure 19 Becton, Dickinson And Company: Segmental Revenue

Figure 20 Becton, Dickinson And Company: Geographical Revenue

Figure 21 Greiner Bio One International GmbH: Key Financials

Figure 22 Greiner Bio One International GmbH: Segmental Revenue

Figure 23 Greiner Bio One International GmbH: Geographical Revenue

Figure 24 Improve Medical Technology Co. Ltd: Key Financials

Figure 25 Improve Medical Technology Co. Ltd: Segmental Revenue

Figure 26 Improve Medical Technology Co. Ltd: Geographical Revenue

Figure 27 Terumo Medical Corporation: Key Financials

Figure 28 Terumo Medical Corporation: Segmental Revenue

Figure 29 Terumo Medical Corporation: Geographical Revenue

Figure 30 ASAHI POLYSLIDER Inc.: Key Financials

Figure 31 ASAHI POLYSLIDER Inc.: Segmental Revenue

Figure 32 ASAHI POLYSLIDER Inc.: Geographical Revenue

Figure 33 ARKRAY: Key Financials

Figure 34 ARKRAY: Segmental Revenue

Figure 35 ARKRAY: Geographical Revenue